
California, US residents click here
The job details are as follows:
Who We Are
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.
United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension ( PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease ( PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis ( PF).
The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
Who You Are
Join the frontlines of innovation in transplant medicine. Lung Bioengineering, a subsidiary of United Therapeutics, is seeking a skilled and mission-driven Ex-Vivo Clinical Specialist II to help transform the future of lung transplantation. In this critical role, you’ll learn to perform ex-vivo lung perfusion (EVLP) procedures to evaluate and optimize donor lungs for transplant—directly impacting patient lives. You’ll work hands-on with advanced clinical technology, collaborate with transplant centers and organ procurement organizations, and help ensure seamless logistics and regulatory compliance. This is more than a job—it’s a unique opportunity to be part of a fast-paced, purpose-driven team on the forefront of life-saving innovation. If you’re a seasoned transplant or critical care professional with strong surgical skills, sterile technique, and a drive to make a difference, we’d love to hear from you.
The Ex-Vivo Clinical Specialist II will develop the skills necessary to perform the clinical ex-vivo lung (EVLP) procedure. This role will evaluate donor lung suitability, manage organ logistics, perform the EVLP procedure, and coordinate with organ procurement organizations and transplant center teams.
Minimum Requirements
Preferred Qualifications
Job Location
This role is based 100% onsite at our facility in Jacksonville, FL, Lung Bioengineering requires this candidate to live within an hour driving distance from the Jacksonville office. Relocation assistance is available as needed.
At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.
Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities
United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.

Founded to find a cure for a daughter’s rare disease, United Therapeutics is a biotechnology company transforming care for people with chronic and life-threatening conditions. Our purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. We are bold and unconventional. We have fun, we do good. We are also the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation.